Nosocomial infections in the immunocompromised adult

The American Journal of Medicine
L S Young

Abstract

It is universally accepted that the immunocompromised host is more susceptible to nosocomial infection than the normal host. Descriptive clinical or epidemiologic studies that utilize the "organism oriented" approach are now abundant. Generalizations about risk factors are difficult to make, however, because of the wide range of host defects that are usually compounded by therapeutic intervention. Comparative data are lacking on whether certain procedures or treatments are associated with a higher incidence of infection in immunocompromised hosts versus normal hosts. Aggressive diagnostic and therapeutic approaches to nosocomial infection in immunocompromised patients are usually advocated, but there have been few prospective studies of their effectiveness and the possible increased hazard of nosocomial infection. The paramount questions that must be addressed are, "What infections are preventable and how?" Two derivative issues relate to (1) the cost to benefit aspects of preventive measures, and (2) the impact of such measures on survival from underlying disease. Rigorously controlled studies of specific preventative measures are clearly required because the appearance of improvement may be related to concurrent improvements ...Continue Reading

Citations

Mar 1, 1985·Diagnostic Microbiology and Infectious Disease·J P HuttonL J Strausbaugh
Apr 1, 1986·Infection and Immunity·S J CryzR Germanier
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·G Lopez-BeresteinR L Juliano
Nov 22, 2011·Vaccine·Tarek A AhmadEl Sayed H El Ashry
Jan 23, 1998·American Journal of Infection Control·E VelascoV M Gonçalves
Jan 1, 1989·Microbial Pathogenesis·S J CryzE Fürer
Jun 1, 1982·The American Journal of Medicine·K A Foon, R P Gale
May 1, 1992·Annals of the Rheumatic Diseases·B GodeauJ R Le Gall
Sep 1, 1981·Hospital Practice·L S Young
Nov 1, 1995·Clinical Nursing Research·K L Rush, L T Haller
Feb 6, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·José Rosselló-UrgellUNKNOWN EPINE Working Group
Aug 1, 1982·European Journal of Clinical Microbiology·D J SmithG M Trenholme
Nov 1, 1983·Infection Control : IC·W Schaffner
Feb 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L S Young
Jan 1, 1985·Annals of the New York Academy of Sciences·R L JulianoK Mills
Dec 20, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Leon J WorthMonica A Slavin
Sep 1, 1992·Antimicrobial Agents and Chemotherapy·V JolyP Yeni
Dec 1, 1984·Journal of Clinical Microbiology·J A SmithD R Burdge
Jun 1, 1994·International Journal of Antimicrobial Agents·O M Korzeniowski
Apr 1, 1986·Journal of Clinical Microbiology·S J CryzR Germanier
Oct 1, 1985·Infection and Immunity·S J CryzR Germanier
Jan 1, 1989·Journal of Clinical Microbiology·U AgnarssonJ R Govan
Feb 15, 2020·Mayo Clinic Proceedings. Innovations, Quality & Outcomes·Rajiv VasudevanDavid T Pride

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

British Journal of Diseases of the Chest
R H ELLIS
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
J H HorinaG Langmann
The Australian Journal of Experimental Biology and Medical Science
J M Cooper, D Rowley
© 2021 Meta ULC. All rights reserved